Switching to Pegmolesatide in Maintenance Dialysis: Real-World Hemoglobin Response, Temporal Dynamics, and Modality-Specific Predictors
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s632477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Chunlei Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Hemoglobins, Renal Dialysis, Anemia, Hematinics. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Zitieren
APA
Luo, C., Bao, S., Ai, Y., Bao, L., Wang, R., Ma, J., & Bian, X. (2026). Switching to Pegmolesatide in Maintenance Dialysis: Real-World Hemoglobin Response, Temporal Dynamics, and Modality-Specific Predictors. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s632477
Vancouver
Luo C, Bao S, Ai Y, Bao L, Wang R, Ma J, et al. Switching to Pegmolesatide in Maintenance Dialysis: Real-World Hemoglobin Response, Temporal Dynamics, and Modality-Specific Predictors. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s632477
BibTeX
@article{Luo2026,
author = {Luo, Chunlei and Bao, Sizeng and Ai, Yuanyuan and Bao, Lingling and Wang, Ruijuan and Ma, Jianwei and Bian, Xueyan},
title = {Switching to Pegmolesatide in Maintenance Dialysis: Real-World Hemoglobin Response, Temporal Dynamics, and Modality-Specific Predictors},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s632477}
}
EUVIMED